GoodRx Holdings, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 197.88 million compared to USD 183.99 million a year ago. Net loss was USD 1.01 million compared to USD 3.29 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.87 USD | +4.10% | +10.22% | +17.46% |
May. 30 | GoodRx Holdings, Inc Announces Board and Committee Changes | CI |
May. 23 | RBC Upgrades GoodRx Holdings to Outperform From Sector Perform, Boosts Price Target to $10 From $8 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.46% | 2.95B | |
+22.55% | 426B | |
+31.87% | 277B | |
+4.92% | 135B | |
+6.46% | 92.01B | |
+23.70% | 89.16B | |
+57.95% | 58.86B | |
+11.34% | 45.02B | |
+19.19% | 34.77B | |
-10.48% | 31.96B |
- Stock Market
- Equities
- GDRX Stock
- News GoodRx Holdings, Inc.
- GoodRx Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024